Justin Mason

Justin Mason is an experienced scientist currently serving as Scientist I at Stylus Medicine since April 2023. Previously, Justin Mason worked at Cell Signaling Technology (CST) for over 16 years, progressing from Production Associate II to Principal Research Associate in the Antibody Development Core with expertise in CRISPR. Key responsibilities included Next Generation Sequencing on the Illumina Platform, improvements to the Antibody discovery pipeline, and extensive hands-on experience with various laboratory robots. Justin Mason holds a Master's degree in Biotechnology with a focus on Bioinformatics from Johns Hopkins University (2018-2022) and a Bachelor's degree in Cell/Cellular and Molecular Biology from the University of Connecticut (2003-2007), along with ongoing studies towards a Master's degree in biotechnology at Harvard Extension School.